BridgeMD
New treatment option for Childhood Cancer
Official title Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment
ClinicalTrials.gov ID: NCT03180918
What this study is testing
- What it's testing
- Background: Due to the remarkable improvement in treatments these last decades, long term survival can be expected in more than 80% of childhood cancer patients. Unfortunately, cancer treatments can be harmful to the gonads and can affect reproductive and endocrine functions.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 3 to 18, men only
You may be able to join if
- Prepubertal patients aged 3 months and older
- Peri and pubertal patients after failure of sperm cryopreservation
- Patients presenting high risk of infertility because of gonadotoxic treatments (i.e high dose of alkylating agents, testicular irradiation, total...
- Multidisciplinary team consensus in favour of proposition to cryopreserve testicular tissue
You likely can't join if
- Patients under the age of 3 months
- Refusal of the patient and/or his parents
- Treatments that are not highly gonadotoxic
The study team makes the final eligibility decision.
Where it's taking place
- Basel, Switzerland
- Geneva, Switzerland
- Lausanne, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 3 months to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Basel, Switzerland; Geneva, Switzerland; Lausanne, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.